Results 111 to 120 of about 62,440 (162)

A Vanished Association Between Proton Pump Inhibitors and Clostridioides Difficile Infection After Minimizing Bias. [PDF]

J Clin Med
Wu B, He Z, Xu T.
europepmc   +1 more source

Tegoprazan Versus Proton Pump Inhibitors for Erosive Esophagitis: A Meta-Analysis of Noninferiority Randomized Controlled Trials. [PDF]

JGH Open
Bhatti MI, Safiullah M, Ijaz A, Mehmood Q, Shahid IF, Shahriar Z.   +5 more
europepmc   +1 more source

Endoscopic Examination and Long-Term Use of Proton Pump Inhibitors for Gastroesophageal Reflux Disease Treatment in Japan. [PDF]

Drug Healthc Patient Saf
Takami A, Terashima G, Shiotsuki Y, Yamashita K, Igarashi A.   +4 more
europepmc   +1 more source

Proton Pump Inhibitors and Histamine-2 Receptor Antagonists in Spinal Fusion: A Systematic Review. [PDF]

Global Spine J
Frappa N, Chernov D, Alben MG, Dillon M, Papalia AG, Riley R, Troiani Z, Lucasti C.   +7 more
europepmc   +1 more source

Potassium-competitive Acid Blockers Versus Proton Pump Inhibitors for Erosive Esophagitis: A Systematic Review and Network Meta-analysis. [PDF]

J Neurogastroenterol Motil
Chang JW, Jung DH, Son NH, Gwon S, Jeong DM, Huh CW.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hypomagnesemia and proton-pump inhibitors

Expert Opinion on Drug Safety, 2013
Proton pump inhibitors (PPIs) have been linked to clinically symptomatic hypomagnesemia.We searched Medline database in all languages using 'proton-pump inhibitors, magnesium, hypomagnesemia and hypomagnesemic hypoparathyroidism' as search terms and other articles were identified through searches of the files of the authors and reference lists from ...
, Giovanni Minisola
exaly   +3 more sources

Deprescribing proton pump inhibitors

Australian Journal of General Practice, 2022
Proton pump inhibitors (PPIs) are indicated for disorders including peptic ulcer disease and gastro-oesophageal reflux disease; however, they are often used for longer and at higher doses than recommended, or for indications that are not supported by evidence.The aim of this article is to outline evidence-based approaches to deprescribing PPIs.PPIs are
Turner, Justin P., Thompson, Wade, Reeve, Emily, Bell, J. Simon   +3 more
openaire   +3 more sources

Overuse of proton pump inhibitors

Journal of Clinical Pharmacy and Therapeutics, 2000
There have been concerns raised about the potential adverse effects of proton pump inhibitors, especially with long-term use. In particular, their potent action can suppress the features and delay the diagnosis of gastric cancer, while prolonged exposure may hasten the development of gastric carcinoids.To examine the use of proton pump inhibitors in ...
M, Naunton, G M, Peterson, M D, Bleasel
openaire   +2 more sources

Proton Pump Inhibitors

Annals of Pharmacotherapy, 2016
Objective: The purpose of this article is to describe the relationship between proton pump inhibitors (PPIs) and symptoms of myopathy based on case reports. Data Sources: A literature search was conducted in PubMed (1946 to June 2016) using MeSH terms proton pump inhibitors, omeprazole, esomeprazole, lansoprazole, dexlansoprazole, rabeprazole ...
Evan W, Colmenares, Ashley L, Pappas
openaire   +2 more sources